Incomplete data stalls Swiss authorisation of Covid-19 vaccines
The government has already placed orders for several million shots of vaccine from three manufacturers: Pfizer/BioNTech, AstraZeneca, and Moderna.
Keystone / John Cairns
Switzerland’s medical regulator Swissmedic says it lacks the necessary information to sign off on three different coronavirus vaccines ordered by the government.
This content was published on
1 minute
Keystone-SDA/ac
Português
pt
Falta de dados atrasa autorização suíça das vacinas Covid-19
The regulator said important data on safety, efficacy and quality are still missing. It has reached out to the manufacturers, who provided data from their studies.
“We lack data on the effectiveness of the clinical trials and on the important subgroups that participated in these large studies,” said Claus Bolte, head of the authorisation division at Swissmedic, at a press briefing on Tuesday organised by the Federal Office of Public Health.
For example, Swissmedic wants to know about the pre-existing illnesses of the people who took part in these studies. According to the regulator, acceptance of such rapidly developed vaccines requires a high degree of trust in manufacturers and approving authorities. It is therefore important to examine very closely the effects on different groups of people.
Rollout plan
The government has already placed orders for several million shots of vaccine from three manufacturers: Pfizer/BioNTech, AstraZeneca, and Moderna.
At the press conference, authorities said vaccines will be offered free of charge and priority will be given to the most vulnerable groups and health workers. The services of the army will be enlisted to ensure stockage and distribution and the country’s 26 cantons will be in charge of setting up vaccination centres.
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Ex-sect member sentenced in Zurich for sexual abuse
This content was published on
Zurich District Court has sentenced a former member of the globally active sect "Children of God" to a partial prison sentence.
SNB chairman does not rule out slowdown in Swiss growth
This content was published on
Martin Schlegel, chairman of the Swiss National Bank (SNB), does not rule out a weakening of the Swiss economy in light of the tariff dispute.
Swiss NGOs abroad to receive 10% less federal funding
This content was published on
In 2025 and 2026, Swiss NGOs will have 10% less federal funding available for international cooperation than in the previous two-year period.
Swiss parties spent less than CHF1 million on February green vote
This content was published on
Swiss political parties spent CHF 700,000 ($840,000) on campaigns in the run-up to the overwhelmingly defeated vote on February 9, according to the Swiss Federal Audit Office.
This content was published on
Swisswool, the largest Swiss wool processor, is not accepting any wool for the first time this spring. For many sheep farmers, the only option is to get rid of the wool.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Can Switzerland convince its people to take the Covid-19 vaccine?
This content was published on
With several vaccines in late stages of development, the next step is to address widespread scepticism so enough people will agree to the jab.
Swiss stump up more cash to buy a Covid-19 vaccine
This content was published on
Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year. So far, Switzerland has assured reservations for about 13 million doses of prospective…
Why Switzerland’s Moderna Covid-19 vaccine deal is risky
This content was published on
Switzerland’s vaccine order – its first such move – is a sign that it holds little hope for fair distribution of a Covid-19 shot.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.